GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,425.50p
   
  • Change Today:
    -3.00p
  • 52 Week High: 1,778.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,100.76m
  • Volume: 6,000,152
  • Market Cap: £58,456m
  • RiskGrade: 129
  • Beta: 0.00

News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
New Research Shows Many Patients with Persistent... 28-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire the Leading Dry Mouth... 21-Oct-2008 PR Newswire
GSK Notice of Third Quarter 2008 Results Announc... 20-Oct-2008 PR Newswire
LF Elimination Program Treats Over Half Billion ... 07-Oct-2008 PR Newswire
alli(TM) Partners with Breast Cancer Network of ... 22-Sep-2008 PR Newswire
MultiVu Video Feed: NEW BRAIN IMAGING SHOWS THE ... 18-Sep-2008 PR Newswire
GSK and XenoPort Announce Submission of New Drug... 16-Sep-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire
GSK Receives Decision From FDA on Advair(R) 500/... 08-Aug-2007 PR Newswire
GlaxoSmithKline Receives New HHS Order for H5N1 ... 03-Aug-2007 PR Newswire
FDA Issues Second Approvable Letter for Trexima(... 02-Aug-2007 PR Newswire
GlaxoSmithKline Presents Avandia Data To FDA 30-Jul-2007 PR Newswire
FDA Advisory Panel Votes 22 to 1 for Avandia(R) ... 30-Jul-2007 PR Newswire
ChemoCentryx Achieves $5 Million Milestone from ... 24-Jul-2007 PR Newswire
GSK's Cervical Cancer Candidate Vaccine Cervarix... 18-Jul-2007 PR Newswire
Pharmacopeia Advances First Therapeutic Program ... 17-Jul-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,425.50p
Change Today -3.00p
% Change -0.21 %
52 Week High 1,778.00
52 Week Low 1,264.00
Volume 6,000,152
Shares Issued 4,100.76m
Market Cap £58,456m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.14% below the market average39.14% below the market average39.14% below the market average39.14% below the market average39.14% below the market average
10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average
Price Trend
0.94% below the market average0.94% below the market average0.94% below the market average0.94% below the market average0.94% below the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Income
73.53% above the market average73.53% above the market average73.53% above the market average73.53% above the market average73.53% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 23-May-2025

Time Volume / Share Price
15:11 0 @ 1,424.00p
15:11 0 @ 1,424.00p
14:49 7 @ 1,424.00p
14:49 7 @ 1,424.50p
16:52 360 @ 1,425.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page